ArticlePloS one2013

The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.

Emma J Haagensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.